Aemetis (NASDAQ:AMTX - Get Free Report)'s stock had its "hold" rating reissued by research analysts at Truist Financial in a report issued on Wednesday, Benzinga reports. They presently have a $3.50 price target on the specialty chemicals company's stock, down from their prior price target of $4.00. Truist Financial's price objective indicates a potential upside of 9.03% from the stock's previous close.
A number of other brokerages have also weighed in on AMTX. HC Wainwright reiterated a "buy" rating and set a $28.00 price objective on shares of Aemetis in a report on Friday, May 10th. StockNews.com upgraded Aemetis to a "sell" rating in a research report on Wednesday. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $12.13.
Get Our Latest Research Report on Aemetis
Aemetis Stock Performance
Shares of AMTX traded down $0.21 during mid-day trading on Wednesday, reaching $3.21. The stock had a trading volume of 792,269 shares, compared to its average volume of 887,035. Aemetis has a 12 month low of $2.75 and a 12 month high of $7.82. The business has a fifty day moving average of $3.31 and a 200 day moving average of $3.71. The firm has a market cap of $142.52 million, a price-to-earnings ratio of -2.86 and a beta of 1.32.
Aemetis (NASDAQ:AMTX - Get Free Report) last announced its quarterly earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.58) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.15). The company had revenue of $72.63 million during the quarter, compared to the consensus estimate of $78.74 million. On average, research analysts forecast that Aemetis will post -1.59 EPS for the current fiscal year.
Insider Transactions at Aemetis
In other Aemetis news, Director John R. Block sold 51,580 shares of the firm's stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $3.49, for a total value of $180,014.20. Following the completion of the sale, the director now directly owns 14,001 shares of the company's stock, valued at approximately $48,863.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 14.34% of the company's stock.
Institutional Trading of Aemetis
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Bank of New York Mellon Corp purchased a new position in shares of Aemetis in the 2nd quarter valued at about $306,000. State Board of Administration of Florida Retirement System acquired a new stake in shares of Aemetis in the first quarter valued at about $84,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Aemetis in the 1st quarter worth approximately $60,000. 27.02% of the stock is owned by institutional investors and hedge funds.
Aemetis Company Profile
(Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
See Also
- Five stocks we like better than Aemetis
- Best Stocks Under $10.00
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Conviction Firms for Microsoft's Double-Digit Stock Upside
- Consumer Discretionary Stocks Explained
- 5 Aggressive Growth Stocks for Long-Term Investors
→ Elon Musk: “This Could be Massive…a Multi Trillion-Dollar Company.” (From Paradigm Press) (Ad)
Should you invest $1,000 in Aemetis right now?
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Metaverse Stocks And Why You Can't Ignore Them
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
